| Sex | Females: 64.5% Males: 35.5% |
| Age | Mean: 32.4 ± 16.5 years (range: 2 weeks-71 years) Mean (Females): 32.1 ± 16.2 years Mean (Males): 32.9 ± 17.6 years |
| Location | Maxilla: 48,3% Mandible: 25.8% Palate: 16.1% Floor of mouth: 6.5% Other: 6.5% |
| Symptoms | Swelling: 67.8% Interference with oral function: 21.4% Facial asymmetry: 10.7% Asymptomatic: 7.1% Other symptoms: 14.3%. |
| Duration | Mean: 30.2 ± 78.9 months (Range: 2 weeks- 30 years) |
| Clinical presentation | Pedunculated mass: 31.2% Soft mass: 32.1% Hard mass: 25.0% Erythematous and/or ulcerated mucosa: 28.1% Tense-elastic mass: 15.6% Firm mass: 12.5% Multilobulated mass: 3.1% Granulomatous mass: 3.1% Generalized gingival hypertrophy: 3.1% Rapid growth: 3.1% |
| Size (cm) | Mean: 3.2 ± 2.7 cm (range 0.5-1.2 cm) |
| Histological diagnosis | Peripheral odontogenic myxoma: 80% Peripheral odontogenic myxofibroma: 20% |
| Odontogenic epithelium | Yes: 30% No/Unknown: 70% |
| Follow-up | Mean: 33 ± 38.5 months (range: 4-156) |